VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) is a publicly traded the market company. As of May 21, 2026, CDC trades at $68.47 with a market cap of $0 and a P/E ratio of 0.00. CDC moved +0.25% today. Year to date, CDC is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces CDC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Emergent Partners with PANTHER to Fund Expansion of MpOx Study after DSMB Clearance: Emergent BioSolutions partnered with PANTHER to fund continuation of the Africa CDC–led MpOx Study after a DSMB review of 50 patients found no safety concerns. Launched in 2024 with EU and Africa CDC support, the trial will expand into Uganda as Emergent drives progress toward the next clinical milestone.
| Metric | Value |
|---|---|
| Price | $68.47 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 119.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
CDC analyst coverage data. Average price target: $0.00.